- Record: found
- Abstract: not found
- Article: not found
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Sana M Al-Khatib, William G Stevenson, Michael J Ackerman, William J Bryant, David J Callans, Anne B Curtis, Barbara J Deal, Timm Dickfeld, Michael E Field, Gregg C Fonarow, Anne M Gillis, Christopher B Granger, Stephen C Hammill, Mark A Hlatky, José A Joglar, G Neal Kay, Daniel D Matlock, Robert J Myerburg, Richard L Page
2018-09-25
AHA Scientific Statements, cardiac electrophysiology, myocardial infarction, athletes, premature ventricular beats, ventricular tachycardia, arrhythmogenic cardiomyopathy, resuscitation, CT imaging, stable coronary artery disease, acute coronary syndrome, specific pathology (eg, congenital heart disease, myocarditis, renal failure), ambulatory ECG monitoring, ventricular fibrillation, sarcoidosis, antiarrhythmic drug therapy, sudden cardiac death, torsades de pointes, medication-induced arrhythmias, ECG, cardiac resynchronization therapy, implantable cardioverter-defibrillator, cardiomyopathy, implantable and external cardioverter devices, catheter ablation, imaging, congenital heart disease, MR imaging, sudden cardiac arrest, heart failure, echocardiography, guidelines, electrophysiological testing, genetic arrhythmias
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
AHA Scientific Statements,cardiac electrophysiology,myocardial infarction,athletes,premature ventricular beats,ventricular tachycardia,arrhythmogenic cardiomyopathy,resuscitation,CT imaging,stable coronary artery disease,acute coronary syndrome,specific pathology (eg, congenital heart disease, myocarditis, renal failure),ambulatory ECG monitoring,ventricular fibrillation,sarcoidosis,antiarrhythmic drug therapy,sudden cardiac death,torsades de pointes,medication-induced arrhythmias,ECG,cardiac resynchronization therapy,implantable cardioverter-defibrillator,cardiomyopathy,implantable and external cardioverter devices,catheter ablation,imaging,congenital heart disease,MR imaging,sudden cardiac arrest,heart failure,echocardiography,guidelines,electrophysiological testing,genetic arrhythmias
AHA Scientific Statements, cardiac electrophysiology, myocardial infarction, athletes, premature ventricular beats, ventricular tachycardia, arrhythmogenic cardiomyopathy, resuscitation, CT imaging, stable coronary artery disease, acute coronary syndrome, specific pathology (eg, congenital heart disease, myocarditis, renal failure), ambulatory ECG monitoring, ventricular fibrillation, sarcoidosis, antiarrhythmic drug therapy, sudden cardiac death, torsades de pointes, medication-induced arrhythmias, ECG, cardiac resynchronization therapy, implantable cardioverter-defibrillator, cardiomyopathy, implantable and external cardioverter devices, catheter ablation, imaging, congenital heart disease, MR imaging, sudden cardiac arrest, heart failure, echocardiography, guidelines, electrophysiological testing, genetic arrhythmias
Comments
Comment on this article
scite_